List of Tables
    Table 1. Non-Tyrosine Kinase Inhibitors CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Non-Tyrosine Kinase Inhibitors Market Trends
    Table 3. Non-Tyrosine Kinase Inhibitors Market Drivers
    Table 4. Non-Tyrosine Kinase Inhibitors Market Challenges
    Table 5. Non-Tyrosine Kinase Inhibitors Market Restraints
    Table 6. Global Non-Tyrosine Kinase Inhibitors Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Non-Tyrosine Kinase Inhibitors Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Non-Tyrosine Kinase Inhibitors Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Non-Tyrosine Kinase Inhibitors Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Non-Tyrosine Kinase Inhibitors Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Non-Tyrosine Kinase Inhibitors Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Non-Tyrosine Kinase Inhibitors Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Non-Tyrosine Kinase Inhibitors Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Non-Tyrosine Kinase Inhibitors Sales Share by Manufacturer, 2017-2022
    Table 15. Global Non-Tyrosine Kinase Inhibitors Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Non-Tyrosine Kinase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Non-Tyrosine Kinase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Tyrosine Kinase Inhibitors as of 2021)
    Table 18. Top Players of Non-Tyrosine Kinase Inhibitors in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Non-Tyrosine Kinase Inhibitors Product Type
    Table 20. Date of International Manufacturers Enter into Non-Tyrosine Kinase Inhibitors Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Non-Tyrosine Kinase Inhibitors Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Non-Tyrosine Kinase Inhibitors Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Non-Tyrosine Kinase Inhibitors Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Non-Tyrosine Kinase Inhibitors Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Non-Tyrosine Kinase Inhibitors Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Non-Tyrosine Kinase Inhibitors Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Non-Tyrosine Kinase Inhibitors Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Non-Tyrosine Kinase Inhibitors Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Non-Tyrosine Kinase Inhibitors Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Non-Tyrosine Kinase Inhibitors Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Non-Tyrosine Kinase Inhibitors Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Non-Tyrosine Kinase Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Non-Tyrosine Kinase Inhibitors Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Non-Tyrosine Kinase Inhibitors Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Non-Tyrosine Kinase Inhibitors Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Non-Tyrosine Kinase Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Non-Tyrosine Kinase Inhibitors Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Non-Tyrosine Kinase Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Non-Tyrosine Kinase Inhibitors Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Non-Tyrosine Kinase Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Roche Corporation Information
    Table 43. Roche Description and Business Overview
    Table 44. Roche Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Roche Non-Tyrosine Kinase Inhibitors Product
    Table 46. Roche Recent Development
    Table 47. Eli Lilly Corporation Information
    Table 48. Eli Lilly Description and Business Overview
    Table 49. Eli Lilly Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Eli Lilly Product
    Table 51. Eli Lilly Recent Development
    Table 52. Novartis Corporation Information
    Table 53. Novartis Description and Business Overview
    Table 54. Novartis Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Novartis Product
    Table 56. Novartis Recent Development
    Table 57. Array BioPharma Corporation Information
    Table 58. Array BioPharma Description and Business Overview
    Table 59. Array BioPharma Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Array BioPharma Product
    Table 61. Array BioPharma Recent Development
    Table 62. Nerviano Medical Sciences Corporation Information
    Table 63. Nerviano Medical Sciences Description and Business Overview
    Table 64. Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Nerviano Medical Sciences Product
    Table 66. Nerviano Medical Sciences Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Merck KGaA Corporation Information
    Table 73. Merck KGaA Description and Business Overview
    Table 74. Merck KGaA Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Merck KGaA Product
    Table 76. Merck KGaA Recent Development
    Table 77. Astex Pharmaceuticals Corporation Information
    Table 78. Astex Pharmaceuticals Description and Business Overview
    Table 79. Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Astex Pharmaceuticals Product
    Table 81. Astex Pharmaceuticals Recent Development
    Table 82. Cyclacel Pharmaceuticals Corporation Information
    Table 83. Cyclacel Pharmaceuticals Description and Business Overview
    Table 84. Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Cyclacel Pharmaceuticals Product
    Table 86. Cyclacel Pharmaceuticals Recent Development
    Table 87. Daiichi Sankyo Corporation Information
    Table 88. Daiichi Sankyo Description and Business Overview
    Table 89. Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Daiichi Sankyo Product
    Table 91. Daiichi Sankyo Recent Development
    Table 92. Onconova Therapeutics Corporation Information
    Table 93. Onconova Therapeutics Description and Business Overview
    Table 94. Onconova Therapeutics Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Onconova Therapeutics Product
    Table 96. Onconova Therapeutics Recent Development
    Table 97. AstraZeneca Corporation Information
    Table 98. AstraZeneca Description and Business Overview
    Table 99. AstraZeneca Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. AstraZeneca Product
    Table 101. AstraZeneca Recent Development
    Table 102. GlaxoSmithKline (GSK) Corporation Information
    Table 103. GlaxoSmithKline (GSK) Description and Business Overview
    Table 104. GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. GlaxoSmithKline (GSK) Product
    Table 106. GlaxoSmithKline (GSK) Recent Development
    Table 107. Carna Biosciences Corporation Information
    Table 108. Carna Biosciences Description and Business Overview
    Table 109. Carna Biosciences Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Carna Biosciences Product
    Table 111. Carna Biosciences Recent Development
    Table 112. Celgene Corporation Corporation Information
    Table 113. Celgene Corporation Description and Business Overview
    Table 114. Celgene Corporation Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Celgene Corporation Product
    Table 116. Celgene Corporation Recent Development
    Table 117. Eternity Bioscience Corporation Information
    Table 118. Eternity Bioscience Description and Business Overview
    Table 119. Eternity Bioscience Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Eternity Bioscience Product
    Table 121. Eternity Bioscience Recent Development
    Table 122. Jasco Pharmaceuticals Corporation Information
    Table 123. Jasco Pharmaceuticals Description and Business Overview
    Table 124. Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 125. Jasco Pharmaceuticals Product
    Table 126. Jasco Pharmaceuticals Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Non-Tyrosine Kinase Inhibitors Customers List
    Table 130. Non-Tyrosine Kinase Inhibitors Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-Tyrosine Kinase Inhibitors Product Picture
    Figure 2. Global Non-Tyrosine Kinase Inhibitors Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Non-Tyrosine Kinase Inhibitors Market Size 2017-2028 (US$ Million)
    Figure 4. Global Non-Tyrosine Kinase Inhibitors Sales 2017-2028 (K Pcs)
    Figure 5. United States Non-Tyrosine Kinase Inhibitors Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Non-Tyrosine Kinase Inhibitors Market Size 2017-2028 (US$ Million)
    Figure 7. United States Non-Tyrosine Kinase Inhibitors Sales 2017-2028 (K Pcs)
    Figure 8. United States Non-Tyrosine Kinase Inhibitors Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Non-Tyrosine Kinase Inhibitors Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Non-Tyrosine Kinase Inhibitors Report Years Considered
    Figure 11. Product Picture of mTOR Inhibitors
    Figure 12. Product Picture of RAF/MEK Inhibitors
    Figure 13. Product Picture of CDK Inhibitors
    Figure 14. Global Non-Tyrosine Kinase Inhibitors Market Share by Type in 2022 & 2028
    Figure 15. Global Non-Tyrosine Kinase Inhibitors Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Non-Tyrosine Kinase Inhibitors Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Non-Tyrosine Kinase Inhibitors Sales by Type (2017-2028) & (K Pcs)
    Figure 18. Global Non-Tyrosine Kinase Inhibitors Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Non-Tyrosine Kinase Inhibitors Price by Type (2017-2028) & (USD/Pcs)
    Figure 20. United States Non-Tyrosine Kinase Inhibitors Market Share by Type in 2022 & 2028
    Figure 21. United States Non-Tyrosine Kinase Inhibitors Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Non-Tyrosine Kinase Inhibitors Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Non-Tyrosine Kinase Inhibitors Sales by Type (2017-2028) & (K Pcs)
    Figure 24. United States Non-Tyrosine Kinase Inhibitors Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Non-Tyrosine Kinase Inhibitors Price by Type (2017-2028) & (USD/Pcs)
    Figure 26. Product Picture of Liver Cancer
    Figure 27. Product Picture of Respiratory Cancer
    Figure 28. Product Picture of Brain Cancer
    Figure 29. Product Picture of Others
    Figure 30. Global Non-Tyrosine Kinase Inhibitors Market Share by Application in 2022 & 2028
    Figure 31. Global Non-Tyrosine Kinase Inhibitors Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Non-Tyrosine Kinase Inhibitors Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Non-Tyrosine Kinase Inhibitors Sales by Application (2017-2028) & (K Pcs)
    Figure 34. Global Non-Tyrosine Kinase Inhibitors Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Non-Tyrosine Kinase Inhibitors Price by Application (2017-2028) & (USD/Pcs)
    Figure 36. United States Non-Tyrosine Kinase Inhibitors Market Share by Application in 2022 & 2028
    Figure 37. United States Non-Tyrosine Kinase Inhibitors Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Non-Tyrosine Kinase Inhibitors Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Non-Tyrosine Kinase Inhibitors Sales by Application (2017-2028) & (K Pcs)
    Figure 40. United States Non-Tyrosine Kinase Inhibitors Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Non-Tyrosine Kinase Inhibitors Price by Application (2017-2028) & (USD/Pcs)
    Figure 42. North America Non-Tyrosine Kinase Inhibitors Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 43. North America Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Non-Tyrosine Kinase Inhibitors Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. Europe Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Non-Tyrosine Kinase Inhibitors Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 54. Asia-Pacific Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Non-Tyrosine Kinase Inhibitors Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 66. Latin America Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Non-Tyrosine Kinase Inhibitors Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Middle East & Africa Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Non-Tyrosine Kinase Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Non-Tyrosine Kinase Inhibitors Value Chain
    Figure 76. Non-Tyrosine Kinase Inhibitors Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed